The European Patent Office (EPO) has published a patent application, EP2026030568A1, concerning degradable branched polymers designed for the delivery of biomolecules. This publication, dated March 18, 2026, details specific International Patent Classification (IPC) codes related to drug formulations, polymer chemistry, and nucleic acid delivery, indicating a focus on pharmaceutical and biotechnological applications.

This patent application is primarily of interest to legal and R&D departments within pharmaceutical and biotechnology companies. As it is a patent publication, it does not impose immediate compliance obligations or deadlines. However, it signifies potential new intellectual property in the field of drug delivery systems, which may impact future research, development, and market strategies for companies operating in this sector.